|本期目录/Table of Contents|

[1]黄赞胜,吴显立,郭洁茹,等.支气管扩张剂雾化吸入在支气管镜检查患者肺功能保护中的临床应用[J].中华肺部疾病杂志,2020,(06):742-745.[doi:10.3877/cma.j.issn.1674-6902.2020.06.005]
 Huang Zansheng,Wu Xianli,Guo Jieru,et al.Clinical use of aerosol inhalation of bronchodilators in the preservation of pulmonary function after bronchoscopy[J].,2020,(06):742-745.[doi:10.3877/cma.j.issn.1674-6902.2020.06.005]
点击复制

支气管扩张剂雾化吸入在支气管镜检查患者肺功能保护中的临床应用(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2020年06期
页码:
742-745
栏目:
论著
出版日期:
2020-12-20

文章信息/Info

Title:
Clinical use of aerosol inhalation of bronchodilators in the preservation of pulmonary function after bronchoscopy
作者:
黄赞胜1吴显立1郭洁茹1王 爽1王 苹1张明周1梁 军12范 晔1
400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学中心1 857000 日喀则,陆军(第三)军医大学第二附属医院附属日喀则第953医院内科2
Author(s):
Huang Zansheng1 Wu Xianli1 Guo Jieru1 Wang Shuang1 Wang Ping1 Zhang Mingzhou1 Liang Jun12 Fan Ye1.
1Respiratory and Critical Care Medical Center, Xinqiao Hospital, Chongqing 400037, China; 2Department of medicine, Shigatse No.953 Hospital affiliated to Xinqiao Hospital, Shigatse 857000, China
关键词:
支气管扩张剂 雾化吸入 支气管镜 肺功能
Keywords:
Bronchodilator Aerosol inhalation Bronchoscope Pulmonary function
分类号:
-
DOI:
10.3877/cma.j.issn.1674-6902.2020.06.005
摘要:
目的 探索操作前应用短效支气管扩张剂雾化吸入对接受支气管镜检查的患者肺功能的保护作用。方法 分析我院2019年2月至2019年4月收治的拟行气管镜检查的患者36例,随机分为对照组和观察组:对照组患者接受操作前常规的丁卡因压缩空气雾化机雾化吸入,观察组患者接受操作前丁卡因联合短效支气管扩张剂压缩空气雾化机雾化吸入; 比较两组患者支气管镜检查前、后生命征、氧饱和度、肺功能指标变化。结果 操作前两组患者生命征、氧饱和度、通气功能指标等均无统计学差异,支气管镜检查后患者的收缩压、氧饱和度、通气功能指标等较操作前明显变化,而接受操作前短效支气管扩张剂雾化吸入的患者通气功能、氧饱和度等指标明显优于对照组患者,而且心率更加稳定。结论 支气管镜操作可导致操作后患者通气功能指标下降,支气管镜操作前应用短效支气管扩张剂雾化吸入治疗可有效保护患者肺功能,提高了围操作期的安全性。
Abstract:
Objective To explore the preservation effect of aerosol inhalation of short-acting bronchodilators on pulmonary function in patients undergoing bronchoscopy. Method A total of 36 patients who were scheduled to undergo bronchoscopy in our hospital from February 2019 to April 2019 were involved and randomly divided into control group or observation group. Patients in the control group received aerosol inhalation of tetracaine through compressed air atomizer before operation as in the observation group short-acting bronchodilator therapy was combined with tetracaine. The vital signs, oxygen saturation and pulmonary function index before and after bronchoscopy were compared between the two groups. Results There was no significant difference in vital signs, oxygen saturation and ventilatory function between the two groups before operation. As the systolic blood pressure, oxygen saturation and ventilatory function changed significantly after bronchoscopy in both groups, short-acting bronchodilator aerosol inhalation significantly improved the ventilation function and oxygen saturation and stabilized heart rate in the observational group than the control group. Conclusion Bronchoscopy performance is able to impair ventilatory function while aerosol inhalation of short-acting bronchodilator before bronchoscopy can effectively preserve the pulmonary function and improve perioperative safety.

参考文献/References:

1 林科雄, 钱桂生. 纤维支气管镜在肺部疾病诊断和治疗中的价值[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(4): 361-363.
2 Kennedy TC, McWilliams A, Edell E, et al. American College of Chest Physicians. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines(2nd edition)[J]. Chest, 2007, 132(3 Suppl): 221S-233S.
3 Du Rand IA, Blaikley J, Booton R, et al. British Thoracic Society Bronchoscopy Guideline Group. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE[J]. Thorax, 2013, 68(Suppl 1): i1-i44.
4 Steinmetz J, Rasmussen LS. The elderly and general anesthesia[J]. Minerva Anestesiol, 2010, 76(9): 745-752.
5 Elston WJ, Whittaker AJ, Khan LN, et al. Safety of research bronchoscopy,biopsy and bronchoalveolar lavage in asthma[J]. Eur Respir J, 2004, 24(3): 375-377.
6 Hattotuwa K, Gamble EA, O'Shaughnessy T, et al. Safety of bronchoscopy,biopsy, and BAL in research patients with COPD[J]. Chest, 2002, 122(6): 1909-1912.
7 Cho J, Choi SM, Park YS, et al. Prediction of cardiopulmonary events using the STOP-Bang questionnaire in patients undergoing bronchoscopy with moderate sedation[J]. Sci Rep, 2020, 10(1): 14471.
8 AlHafidh OZ, Sidhu JS, Virk J, et al. Incidence, Predictors, Causes,and Cost of 30-Day Hospital Readmission in Chronic Obstructive Pulmonary Disease Patients Undergoing Bronchoscopy[J]. Cureus, 2020, 12(6): e8607.
9 Price D, Fromer L, Kaplan A, et al. Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?[J]. NPJ Prim Care Respir Med, 2014, 24: 14023.
10 田 曼, 葛传生, 麦根荣. 病毒感染引起气道高反应性的神经-受体机制[J]. 中华结核和呼吸杂志, 2002, 25(1): 45-47.
11 Barnes PJ. Distribution of receptor targets in the lung[J]. Proc Am Thorac Soc, 2004, 1(4): 345-351.
12 Proskocil BJ, Fryer AD. Beta2-agonist and anticholinergic drugs in the treatment of lung disease[J]. Proc Am Thorac Soc, 2005, 2(4): 305-310.
13 Boaventura LC, Araujo AC, Martinez JB, et al. Effects of ipratropium on exercise-induced bronchospasm[J]. Int J Sports Med, 2010, 31(7): 516-520.
14 Inoue H, Aizawa H, Takata S, et al. Ipratropium bromide protects against bronchoconstriction during bronchoscopy[J]. Lung, 1994, 172(5): 293-298.
15 张见平, 刘 冬. 纤维支气管镜检查前吸入沙丁胺醇保护稳定期哮喘患者[J]. 河南医药信息, 2002, 10(2): 13-15.
16 Sharma A, Madaan A. Nebulized salbutamol vs salbutamol and ipratropium combination in asthma[J]. Indian J Pediatr, 2004, 71(2): 121-124.
17 Iramain R, López-Herce J, Coronel J, et al. Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children[J]. J Asthma, 2011, 48(3): 298-303.

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金资助项目(81570051)
通信作者: 梁 军, Email: 83728087@qq.com
更新日期/Last Update: 2020-12-20